Advanced radiotherapy for prostate cancer to cut sessions from 20 to 5
Thousands of men in England who have prostate cancer will be offered high-powered precision radiotherapy that will slash the number of treatment sessions they typically need from 20 to just five.
Senior doctors said the technique – called SABR (stereotactic ablative radiotherapy) - would target the disease more effectively than standard radiotherapy and help reduce side-effects.
The treatment is already offered to some patients with other types of cancer, including lung and brain.
This is the first time it will be offered to low- and intermediate-risk prostate cancer patients outside of trials.
Of the 55,000 men diagnosed with prostate cancer each year, around 17,500 are deemed low or intermediate risk.
NHS England said it expected all 48 radiotherapy centres around the country to start offering the treatment "within weeks".
Source: BBC News, 10 June 2026